Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-61,969
| Closed | -$9.78M | – | 614 |
|
|
2025
Q2 | $9.78M | Buy |
61,969
+26,273
| +74% | +$3.88M | 0.03% | 404 |
|
|
2025
Q1 | $4.82M | Buy |
35,696
+1,317
| +4% | +$184K | 0.02% | 552 |
|
|
2024
Q4 | $4.95M | Sell |
34,379
-86,301
| -72% | -$14.4M | 0.02% | 542 |
|
|
2024
Q3 | $19.7M | Buy |
120,680
+34,715
| +40% | +$5.25M | 0.06% | 279 |
|
|
2024
Q2 | $12.5M | Buy |
85,965
+65,917
| +329% | +$9.21M | 0.04% | 355 |
|
|
2024
Q1 | $2.63M | Sell |
20,048
-696
| -3% | -$83K | 0.01% | 708 |
|
|
2023
Q4 | $2.25M | Buy |
20,744
+744
| +4% | +$75.8K | 0.01% | 715 |
|
|
2023
Q3 | $1.84M | Buy |
20,000
+10,715
| +115% | +$1.01M | 0.01% | 721 |
|
|
2023
Q2 | $822K | Sell |
9,285
-63
| -0.7% | -$5.37K | ﹤0.01% | 869 |
|
|
2023
Q1 | $861K | Sell |
9,348
-37,441
| -80% | -$3.62M | ﹤0.01% | 890 |
|
|
2022
Q4 | $4.92M | Sell |
46,789
-15,447
| -25% | -$1.58M | 0.02% | 604 |
|
|
2022
Q3 | $5.44M | Buy |
+62,236
| New | +$6.08M | 0.02% | 559 |
|
|
2021
Q4 | – | Sell |
-3,923
| Closed | -$377K | – | 1235 |
|
|
2021
Q3 | $377K | Sell |
3,923
-316,765
| -99% | -$31.4M | ﹤0.01% | 1106 |
|
|
2021
Q2 | $32.4M | Sell |
320,688
-24,994
| -7% | -$2.57M | 0.09% | 259 |
|
|
2021
Q1 | $33.3M | Buy |
345,682
+53,600
| +18% | +$5.42M | 0.1% | 239 |
|
|
2020
Q4 | $30.7M | Buy |
292,082
+105,039
| +56% | +$10.1M | 0.1% | 233 |
|
|
2020
Q3 | $16.7M | Buy |
187,043
+184,893
| +8,600% | +$16.7M | 0.06% | 326 |
|
|
2020
Q2 | $201K | Buy |
+2,150
| New | +$212K | ﹤0.01% | 1176 |
|
|
2020
Q1 | – | Sell |
-180,600
| Closed | -$17.7M | – | 1215 |
|
|
2019
Q4 | $17.7M | Buy |
180,600
+175,500
| +3,441% | +$15.5M | 0.07% | 318 |
|
|
2019
Q3 | $437K | Buy |
+5,100
| New | +$427K | ﹤0.01% | 1118 |
|
|
2018
Q4 | – | Sell |
-208,034
| Closed | -$14.4M | – | 1340 |
|
|
2018
Q3 | $14.4M | Sell |
208,034
-123,700
| -37% | -$8.4M | 0.05% | 380 |
|
|
2018
Q2 | $19.6M | Sell |
331,734
-774
| -0.2% | -$48.3K | 0.08% | 293 |
|
|
2018
Q1 | $21.7M | Sell |
332,508
-31,800
| -9% | -$2.1M | 0.09% | 270 |
|
|
2017
Q4 | $23.5M | Sell |
364,308
-204,800
| -36% | -$12.8M | 0.09% | 259 |
|
|
2017
Q3 | $33.7M | Buy |
569,108
+115,931
| +26% | +$6.46M | 0.15% | 203 |
|
|
2017
Q2 | $23.4M | Buy |
453,177
+24,747
| +6% | +$1.32M | 0.11% | 231 |
|
|
2017
Q1 | $21.9M | Buy |
428,430
+164,500
| +62% | +$8.47M | 0.1% | 252 |
|
|
2016
Q4 | $13.5M | Buy |
263,930
+37,300
| +16% | +$1.74M | 0.06% | 340 |
|
|
2016
Q3 | $9.81M | Buy |
226,630
+73,030
| +48% | +$3.32M | 0.04% | 403 |
|
|
2016
Q2 | $7.35M | Sell |
153,600
-33,820
| -18% | -$1.67M | 0.03% | 469 |
|
|
2016
Q1 | $9.43M | Buy |
+187,420
| New | +$8.94M | 0.04% | 407 |
|
|
2015
Q4 | – | Sell |
-67,100
| Closed | -$2.77M | – | 1447 |
|
|
2015
Q3 | $2.77M | Buy |
67,100
+33,200
| +98% | +$1.39M | 0.01% | 708 |
|
|
2015
Q2 | $1.37M | Buy |
+33,900
| New | +$1.42M | 0.01% | 889 |
|
|
2014
Q4 | – | Sell |
-72,200
| Closed | -$2.48M | – | 1440 |
|
|
2014
Q3 | $2.48M | Buy |
+72,200
| New | +$2.66M | 0.01% | 690 |
|
|
2014
Q2 | – | Sell |
-25,800
| Closed | -$912K | – | 1412 |
|
|
2014
Q1 | $912K | Buy |
+25,800
| New | +$1.15M | ﹤0.01% | 937 |
|
|
2013
Q3 | – | Sell |
-85,050
| Closed | -$2.92M | – | 1297 |
|
|
2013
Q2 | $2.92M | Buy |
+85,050
| New | +$3.02M | 0.02% | 614 |
|
Other funds holding LDOS
Axa's LDOS Position: Q3 2025 in Review
Axa sold out of Leidos (LDOS) in Q3 2025, closing a stake of 61,969 shares — an estimated $9.78M sold.
Axa first reported a position in LDOS in Q2 2013 and held it in 36 quarters. The position peaked at $33.7M in Q3 2017. 902 funds tracked by Wall St. Rank hold LDOS as of Q3 2025.
- Axa reported no remaining Leidos position as of Q3 2025 after selling out during the quarter.
- Axa sold 61,969 Leidos shares in Q3 2025, an estimated $9.78M.
- Axa first reported a position in Leidos in Q2 2013 and held it in 36 quarters.
- Axa's Leidos position peaked at $33.7M in Q3 2017.
- 902 funds tracked by Wall St. Rank held Leidos as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.